Amundi’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-600,815
| Closed | -$69.9M | – | 2102 |
|
2023
Q3 | $69.9M | Buy |
600,815
+213,350
| +55% | +$24.8M | 0.03% | 427 |
|
2023
Q2 | $39.9M | Buy |
387,465
+93,064
| +32% | +$9.59M | 0.02% | 565 |
|
2023
Q1 | $31.8M | Buy |
294,401
+10,052
| +4% | +$1.09M | 0.02% | 610 |
|
2022
Q4 | $32.2M | Buy |
284,349
+7,734
| +3% | +$875K | 0.02% | 595 |
|
2022
Q3 | $18.5M | Buy |
276,615
+125,012
| +82% | +$8.38M | 0.01% | 709 |
|
2022
Q2 | $12M | Sell |
151,603
-12,531
| -8% | -$996K | 0.01% | 732 |
|
2022
Q1 | $18.4M | Sell |
164,134
-10,871
| -6% | -$1.22M | 0.01% | 691 |
|
2021
Q4 | $15.8M | Sell |
175,005
-16,573
| -9% | -$1.5M | 0.01% | 739 |
|
2021
Q3 | $21M | Sell |
191,578
-25,667
| -12% | -$2.81M | 0.01% | 675 |
|
2021
Q2 | $20.3M | Buy |
+217,245
| New | +$20.3M | 0.01% | 675 |
|